Pacific Biosciences Of California (PACB) Other Non Operating Income (2010 - 2026)

Pacific Biosciences Of California's Other Non Operating Income history runs 17 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 53.28% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was -$2.3 million, a 7.18% increase from a year earlier, with the FY2023 full-year figure at $32.7 million, changed N/A from the prior year.
• Other Non Operating Income improved to $2.0 million in Q1 2026 per PACB's latest filing, from -$12.0 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $34.7 million in Q4 2023 and bottomed at -$19.7 million in Q4 2024.
• The 5-year median for Other Non Operating Income is $4.3 million (2025), against an average of $3.5 million.
• Across the five-year window, Other Non Operating Income plunged 129100.0% in 2022 and soared 2791.24% in 2023, its largest moves.
• Year by year, Other Non Operating Income stood at -$1.3 million in 2022, then surged by 2791.24% to $34.7 million in 2023, then plunged by 156.8% to -$19.7 million in 2024, then surged by 39.2% to -$12.0 million in 2025, then soared by 116.73% to $2.0 million in 2026.
• Per Business Quant, the three latest PACB Other Non Operating Income figures stand at $2.0 million (Q1 2026), -$12.0 million (Q4 2025), and $3.0 million (Q3 2025).